These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19464224)

  • 1. Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.
    Hervier B; Masseau A; Mussini JM; Audrain M; Hamidou MA
    Joint Bone Spine; 2009 Oct; 76(5):575-6. PubMed ID: 19464224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antisynthetase syndrome with good response to mycophenolate mofetil].
    López de la Osa A; Sánchez Tapia C; Arias Díaz M; Terrancle de Juan I
    Rev Clin Esp; 2007 May; 207(5):269-70. PubMed ID: 17504680
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
    Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
    Sakanoue M; Kawai K; Kanekura T
    J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
    [No Abstract]   [Full Text] [Related]  

  • 5. Graves' disease associated with primary systemic sclerosis.
    Wimmersberger Y; Zuercher D
    Orbit; 2009; 28(4):262-3. PubMed ID: 19839886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
    Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic therapy of atopic dermatitis in children and adults.
    Simon D
    Curr Probl Dermatol; 2011; 41():156-164. PubMed ID: 21576956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.
    Hamilton BK; Bolwell B; Kalaycio M; Rybicki L; Hanna R; Sobecks R; Pohlman B; Andresen S; Dean R; Duong H; Hill B; Copelan E
    Bone Marrow Transplant; 2013 Nov; 48(12):1578-80. PubMed ID: 23749105
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C; Honma N; Tanaka R; Oh-ishi T
    Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.
    Loftus CG; Egan LJ; Sandborn WJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):141-69, vii. PubMed ID: 15177532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive therapy in children.
    Prasad R; Singh UK; Mittal R; Mishra OP
    J Indian Med Assoc; 2011 Feb; 109(2):101-2, 104-7. PubMed ID: 21888174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycophenolate mofetil and cyclosporine in the treatment of steroid-dependent nephrotic syndrome with frequent relapses].
    Márquez Peiró JF; Porta Oltra B; Marín Serra J
    An Pediatr (Barc); 2008 Sep; 69(3):258-62. PubMed ID: 18775272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A.
    Glanemann M; Klupp J; Langrehr JM; Schröer G; Platz KP; Stange B; Settmacher U; Bechstein WO; Neuhaus P
    Transplant Proc; 2000 May; 32(3):522-3. PubMed ID: 10812095
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome.
    Agarwal DK; Gulati S; Mehta A; Kumar A; Sharma RK; Mehta B; Gupta A; Gupta RK
    Nephrol Dial Transplant; 2000 Dec; 15(12):2064-5. PubMed ID: 11096161
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving new therapies of autoimmune hepatitis.
    Vierling JM; Flores PA
    Clin Liver Dis; 2002 Aug; 6(3):825-50, ix. PubMed ID: 12362583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mycophenolate mofetil for steroid and cyclosporine resistant membranoproliferative glomerulonephritis type I.
    Ito S; Tsutsumi A; Inaba A; Machida H; Harada T; Yokota S
    Pediatr Nephrol; 2009 Aug; 24(8):1593-4. PubMed ID: 19224249
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyclosporine A in treatment of lupus nephritis resistant to cyclophosphamide and mycophenolate mofetil: a case report].
    Mellor-Pita S; Yebra Bango M; Tutor-Ureta P; Fernández J
    Rev Clin Esp; 2006 Oct; 206(9):464-5. PubMed ID: 17042994
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report.
    Chueh SC; Hong JC; Huang CY; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1925-6. PubMed ID: 11120003
    [No Abstract]   [Full Text] [Related]  

  • 20. Is cyclosporin the immunosuppressant of choice for liver transplantation for erythropoietic protoporphyria?
    Nash KL; Cox TM; Alexander GJ
    Transpl Int; 2008 Feb; 21(2):192-3. PubMed ID: 17944799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.